TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 37097308

Group type: EXPERIMENTAL
Intervention: Telerehabilitation exercise program (clinical Pilates-based exercises via YouTube, performed twice daily for 8 weeks)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (home exercise program using printed brochures for 8 weeks)
Number of subjects: 46
Study: 34468410

Group type: EXPERIMENTAL
Intervention: Automated microneedling
Number of subjects: 30

Group type: COMPARATOR
Intervention: Fractional CO2 laser
Number of subjects: 30
Study: 32352320

Group type: EXPERIMENTAL
Intervention: Atezolizumab plus bevacizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active surveillance
Number of subjects: 0
Study: 35373340

Group type: EXPERIMENTAL
Intervention: Subgingival air-polishing therapy with erythritol powder (EPAP) as adjunct to conventional subgingival instrumentation
Number of subjects: 21

Group type: COMPARATOR
Intervention: Conventional subgingival instrumentation alone
Number of subjects: 21
Study: 33637231

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Hearing aids
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Sound stimulation
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Structured counseling
Number of subjects: 500

Group type: COMPARATOR
Intervention: Combination treatments
Number of subjects: 500
Study: 32866624

Group type: EXPERIMENTAL
Intervention: CoMut (coexisting mutations)
Number of subjects: 542
Study: 34672254

Group type: EXPERIMENTAL
Intervention: Test formulation of terazosin hydrochloride (2 mg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Reference formulation of terazosin hydrochloride (2 mg)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Fasting condition
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Fed condition
Number of subjects: 48
Study: 32992785

Group type: EXPERIMENTAL
Intervention: SRP + VD 25,000 IU/week
Number of subjects: 27

Group type: COMPARATOR
Intervention: SRP + placebo
Number of subjects: 27
Study: 36113187

Group type: EXPERIMENTAL
Intervention: Fully no-touch technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional cephalic vein inflation
Number of subjects: 0
Study: 32096586

Group type: EXPERIMENTAL
Intervention: Radiomics nomogram based on multiparametric MRI (mpMRI) features including T1 WI, FS-T2 WI, CE, DWI, and ADC maps.
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Radiomics nomogram based on multiparametric MRI (mpMRI) features.
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Radiomics nomogram incorporating MRI-reported LN status and FIGO stage.
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Radiomics nomogram.
Number of subjects: 233
Study: 33430189

Group type: EXPERIMENTAL
Intervention: Multi-component lifestyle intervention against cognitive decline
Number of subjects: 1030
Study: 32498367

Group type: EXPERIMENTAL
Intervention: National Exercise Referral Scheme (NERS)
Number of subjects: 83598
Study: 34069308

Group type: EXPERIMENTAL
Intervention: Cooking classes (6 weeks, once per week)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Meal kit provision (6 weekly kits, 3 meals per kit)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 0
Study: 32871473

Group type: EXPERIMENTAL
Intervention: Sirolimus
Number of subjects: 67

Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 67
Study: 34142896

Group type: EXPERIMENTAL
Intervention: Trunk exercise program
Number of subjects: 28

Group type: COMPARATOR
Intervention: Upper and lower limb exercises (Control)
Number of subjects: 28
Study: 33226524

Group type: EXPERIMENTAL
Intervention: darolutamide 600 mg twice daily
Number of subjects: 95

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 95
Study: 32967616

Group type: EXPERIMENTAL
Intervention: Underwater endoscopic mucosal resection (UEMR)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Conventional endoscopic mucosal resection (CEMR)
Number of subjects: 142
Study: 36243580

Group type: EXPERIMENTAL
Intervention: HYR-PB21 300 mg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: HYR-PB21 150 mg
Number of subjects: 72

Group type: COMPARATOR
Intervention: Bupivacaine HCl 75 mg
Number of subjects: 72
Study: 33123730

Group type: EXPERIMENTAL
Intervention: Cannabis sativa oil (1g of cannabis in 10g of olive oil) for 4 weeks
Number of subjects: 17
Study: 32351642

Group type: EXPERIMENTAL
Intervention: Empathy condition (SAR robot programmed with empathy)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Distraction condition (SAR robot programmed with distraction)
Number of subjects: 31

Group type: COMPARATOR
Intervention: No robot (control group)
Number of subjects: 31
Study: 35799673

Group type: EXPERIMENTAL
Intervention: Logistic regression model
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: XGBoost algorithm model
Number of subjects: 200
Study: 33822406

Group type: EXPERIMENTAL
Intervention: CT‐P17 AI (40 mg/0.4 mL)
Number of subjects: 193

Group type: COMPARATOR
Intervention: CT‐P17 PFS (40 mg/0.4 mL)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: CT‐P17 AI and CT‐P17 PFS
Number of subjects: 193
Study: 33730255

Group type: EXPERIMENTAL
Intervention: Prior HCV test
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Prior diagnosis of HCV
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Received treatment for HCV
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Cured of HCV
Number of subjects: 399
Study: 33345474

Group type: EXPERIMENTAL
Intervention: 16G puncture needle
Number of subjects: 142

Group type: COMPARATOR
Intervention: 18G puncture needle
Number of subjects: 142
Study: 36197287

Group type: EXPERIMENTAL
Intervention: Aprepitant
Number of subjects: 130

Group type: COMPARATOR
Intervention: Desloratadine
Number of subjects: 130
Study: 33524293

Group type: EXPERIMENTAL
Intervention: Rifaximin (600 mg twice daily)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197
Study: 32869564

Group type: EXPERIMENTAL
Intervention: BNO 1045 (Canephron®N)
Number of subjects: 657

Group type: COMPARATOR
Intervention: FT (fosfomycin trometamol)
Number of subjects: 657
Study: 32291360

Group type: EXPERIMENTAL
Intervention: SCT-based anti-bullying intervention
Number of subjects: 280

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 280
Study: 35612469

Group type: EXPERIMENTAL
Intervention: Biofeedback video game with mirroring visualizations
Number of subjects: 67

Group type: COMPARATOR
Intervention: Biofeedback video game without mirroring visualizations
Number of subjects: 67
Study: 33600092

Group type: EXPERIMENTAL
Intervention: CPC/GK2/TXA mouthwash used 3x/day for 7 to 10 days postoperatively
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo mouthwash
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: CPC/GK2/TXA mouthwash
Number of subjects: 20
Study: 33136048

Group type: EXPERIMENTAL
Intervention: Mandibular overdentures retained by implants with 2 Locator attachments
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional dentures
Number of subjects: 20
Study: 616386675

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MedDiet)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Habitual diet (HabDiet)
Number of subjects: 166
Study: 34846603

Group type: EXPERIMENTAL
Intervention: Energy-reduced Mediterranean diet (MedDiet) intervention
Number of subjects: 2985
Study: 33186998

Group type: EXPERIMENTAL
Intervention: Spaced learning concept
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional methods
Number of subjects: 34
Study: 33262577

Group type: COMPARATOR
Intervention: Escitalopram oxalate 20 mg tablets (generic)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Lexapro® (brand name)
Number of subjects: 24
Study: 616571495

Group type: EXPERIMENTAL
Intervention: Acoustically isolated room
Number of subjects: 24

Group type: COMPARATOR
Intervention: Domestic environment
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sleep lab
Number of subjects: 24
Study: 33548159

Group type: EXPERIMENTAL
Intervention: Irinotecan (IRI)
Number of subjects: 487

Group type: COMPARATOR
Intervention: Oxaliplatin (OX)
Number of subjects: 487
Study: 35247214

Group type: EXPERIMENTAL
Intervention: Plasma exchange therapy (PE)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Historical control (no plasma exchange)
Number of subjects: 20
Study: 34031262

Group type: EXPERIMENTAL
Intervention: COBRA Slim (MTX 15mg with step-down glucocorticoid scheme)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Tight-Step-Up (TSU) (MTX without oral GCs)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Comparison of total NSAID and analgesic use
Number of subjects: 90

Group type: COMPARATOR
Intervention: Comparison of chronic NSAID and analgesic use
Number of subjects: 90

Group type: COMPARATOR
Intervention: Comparison of daily chronic NSAID use
Number of subjects: 90
Study: 33219150

Group type: EXPERIMENTAL
Intervention: DIANES score (based on IA diameter, indication, parent artery diameter ratio, neck ratio, side-branch artery, and sex)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: DIANES score
Number of subjects: 146
Study: 32918519

Group type: EXPERIMENTAL
Intervention: FACE Advance Care Planning intervention
Number of subjects: 126
Study: 33026143

Group type: EXPERIMENTAL
Intervention: efpeglenatide (4 mg or 6 mg)
Number of subjects: 4076

Group type: COMPARATOR
Intervention: masked placebo
Number of subjects: 4076
Study: 33189178

Group type: EXPERIMENTAL
Intervention: Selinexor (100 mg once per week), bortezomib (1.3 mg/m2 once per week), and dexamethasone (20 mg twice per week)
Number of subjects: 402

Group type: COMPARATOR
Intervention: Bortezomib (1.3 mg/m2 twice per week for the first 24 weeks and once per week thereafter) and dexamethasone (20 mg four times per week for the first 24 weeks and twice per week thereafter)
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Selinexor, bortezomib, and dexamethasone
Number of subjects: 402

Group type: COMPARATOR
Intervention: Bortezomib and dexamethasone
Number of subjects: 402
Study: 33338442

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel plus gemcitabine
Number of subjects: 130

Group type: COMPARATOR
Intervention: sequential FOLFIRINOX
Number of subjects: 130
Study: 33964325

Group type: EXPERIMENTAL
Intervention: 4 months of androgen deprivation therapy (ADT) plus high-dose radiotherapy (HRT)
Number of subjects: 355

Group type: COMPARATOR
Intervention: 24 months of ADT following 4 months of ADT plus HRT
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Time to testosterone recovery after ADT
Number of subjects: 355
Study: 33427180

Group type: EXPERIMENTAL
Intervention: Public speaking task (Trier Social Stress Test - modified for children, TSST-M) with parent (N = 59)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Public speaking task (Trier Social Stress Test - modified for children, TSST-M) alone (N = 60)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control condition (no TSST-M, N = 61)
Number of subjects: 180
Study: 34561086

Group type: EXPERIMENTAL
Intervention: saline
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: 1% hydrogen peroxide
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: 0.5% povidone-iodine
Number of subjects: 201
Study: 33485371

Group type: EXPERIMENTAL
Intervention: VTS Glove (vibrotactile stimulation)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (identical glove with vibration disabled)
Number of subjects: 16
Study: 32294560

Group type: EXPERIMENTAL
Intervention: Lidocaine 7% and Tetracaine 7% self-occlusive cream (LT-C), applied 1 hour before MAL-cPDT session.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Vehicle cream (control group).
Number of subjects: 50

Group type: COMPARATOR
Intervention: Comparison of LT-C vs Vehicle cream.
Number of subjects: 50
Study: 36371994

Group type: EXPERIMENTAL
Intervention: Trastuzumab-plus-chemotherapy group (n = 36)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Trastuzumab-monotherapy group (n = 52)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Non-trastuzumab group (n = 32)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 123
Study: 34185752

Group type: EXPERIMENTAL
Intervention: Psychological counseling combined with outdoor exercise
Number of subjects: 160

Group type: COMPARATOR
Intervention: Routine in-campus education of health knowledge related to the epidemic
Number of subjects: 160
Study: 32172488

Group type: EXPERIMENTAL
Intervention: YLB113
Number of subjects: 52

Group type: COMPARATOR
Intervention: Etanercept RP (Enbrel)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: YLB113 and Etanercept RP
Number of subjects: 52
Study: 33730409

Group type: EXPERIMENTAL
Intervention: Partial middle turbinate resection
Number of subjects: 38

Group type: COMPARATOR
Intervention: Bolgerization of the middle turbinate
Number of subjects: 38
Study: 32183768

Group type: EXPERIMENTAL
Intervention: Eurythmy therapy (EYT)
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Tai Chi
Number of subjects: 550

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Eurythmy therapy (EYT) and Tai Chi
Number of subjects: 550
Study: 36107586

Group type: EXPERIMENTAL
Intervention: Double operator technique
Number of subjects: 47

Group type: COMPARATOR
Intervention: Single operator technique
Number of subjects: 47

Group type: COMPARATOR
Intervention: Single operator techniques
Number of subjects: 47
Study: 33245905

Group type: EXPERIMENTAL
Intervention: Beta-blocker therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitor (ACEI) therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Target dosing of beta-blocker and ACEI therapy
Number of subjects: 0
Study: 32819445

Group type: EXPERIMENTAL
Intervention: Combined group (IV-TXA 15 mg/kg + local TXA 2 g)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: IV group (IV-TXA 15 mg/kg)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Topical group (local TXA 2 g)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Control group (100 mL IV)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 280
Study: 35557091

Group type: COMPARATOR
Intervention: Standardized Patient (STP)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: High-fidelity Human Patient Simulation (HPS)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Didactic Lecture
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Overall Learning Environments (Didactic, STP, HPS)
Number of subjects: 66
Study: 33557988

Group type: EXPERIMENTAL
Intervention: Intervention to improve hand hygiene compliance
Number of subjects: 0
Study: 35980383

Group type: EXPERIMENTAL
Intervention: Exercise intervention program consisting of two supervised resistance exercise sessions per week plus individual aerobic exercise recommendations for 8 weeks.
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Exercise intervention program
Number of subjects: 32
Study: 33048875

Group type: EXPERIMENTAL
Intervention: Combination prevention intervention with universal ART (Arm A)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Prevention intervention with ART provided according to local guidelines (Arm B)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard-of-care (Arm C)
Number of subjects: 200
Study: 33138177

Group type: EXPERIMENTAL
Intervention: ERT-based model for estimating Rs values using routine meteorological observations (2000-2015)
Number of subjects: 756

Group type: EXPERIMENTAL
Intervention: Long-term variation trends of Rs at 454 stations (1970-2015)
Number of subjects: 756

Group type: EXPERIMENTAL
Intervention: Long-term variation trends of Rs during 1970-1992
Number of subjects: 756

Group type: EXPERIMENTAL
Intervention: Long-term variation trends of Rs during 1992-2015
Number of subjects: 756

Group type: EXPERIMENTAL
Intervention: Recovery trends at individual stations during 1970-2015
Number of subjects: 756
Study: 34081487

Group type: EXPERIMENTAL
Intervention: CDI-only
Number of subjects: 528

Group type: EXPERIMENTAL
Intervention: CDI plus PNF-only booster
Number of subjects: 528

Group type: EXPERIMENTAL
Intervention: CDI plus PNF and PBS feedback booster
Number of subjects: 528

Group type: COMPARATOR
Intervention: All conditions
Number of subjects: 528
Study: 34940806

Group type: EXPERIMENTAL
Intervention: PCV20
Number of subjects: 1000

Group type: COMPARATOR
Intervention: PCV13
Number of subjects: 1000

Group type: COMPARATOR
Intervention: PPSV23
Number of subjects: 1000
Study: 32997825

Group type: EXPERIMENTAL
Intervention: VEGF A and VEGFR2 gene polymorphisms
Number of subjects: 273

Group type: COMPARATOR
Intervention: Control group (100 healthy blood donors)
Number of subjects: 273
Study: 32773450

Group type: COMPARATOR
Intervention: Myostatin inhibitors
Number of subjects: 0
Study: 35347399

Group type: EXPERIMENTAL
Intervention: Balneological treatment (peloidotherapy + hydrotherapy)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (peloid applied over a stretch film cover)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Both groups (balneological treatment and control)
Number of subjects: 64
Study: 33971731

Group type: EXPERIMENTAL
Intervention: Services from a multidisciplinary team that includes integrated supported employment
Number of subjects: 2960

Group type: COMPARATOR
Intervention: Services as usual
Number of subjects: 2960

Group type: EXPERIMENTAL
Intervention: Services from a similar team that includes a nurse care coordinator for medication management support and medical care
Number of subjects: 2960
Study: 32603613

Group type: EXPERIMENTAL
Intervention: 1.1 GBq I‐131
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 3.7 GBq I‐131
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 160
Study: 35629233

Group type: EXPERIMENTAL
Intervention: Ramosetron (0.3 mg after anesthetic induction)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control (normal saline)
Number of subjects: 56
Study: 32335950

Group type: COMPARATOR
Intervention: 0.0 mg oestradiol benzoate (0EB group; n=12)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 0.5 mg oestradiol benzoate (0.5EB group; n=12)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 1.0 mg oestradiol benzoate (1.0EB group; n=12)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Overall (all groups)
Number of subjects: 36
Study: 35142535

Group type: EXPERIMENTAL
Intervention: BTL-TML (low-dose Thimerosal)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 22
Study: 34006462

Group type: EXPERIMENTAL
Intervention: Virtual Reality intervention
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 78
Study: 32828837

Group type: EXPERIMENTAL
Intervention: Prospectively registered trials
Number of subjects: 196

Group type: COMPARATOR
Intervention: Retrospectively registered trials
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Trials with non-significant difference between treatments for primary outcome
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Registered trials
Number of subjects: 196
Study: 35334605

Group type: EXPERIMENTAL
Intervention: Listening to music during colposcopy (Group 1)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (no music, no headphones)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Colposcopy while wearing headphones but not listening to music (Group 2)
Number of subjects: 240
Study: 33388816

Group type: EXPERIMENTAL
Intervention: Left arm group (no visual feedback)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Right arm group (with increasing task experience and sensory information)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Left arm group (with increasing task experience and sensory information)
Number of subjects: 40
Study: 33306419

Group type: EXPERIMENTAL
Intervention: Health-Promoting Lifestyle Education Program
Number of subjects: 88

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 88
Study: 35106942

Group type: EXPERIMENTAL
Intervention: HealthyMoms app
Number of subjects: 305
Study: 32816324

Group type: EXPERIMENTAL
Intervention: High tibial osteotomy (HTO)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (48 older healthy participants)
Number of subjects: 24
Study: 36196533

Group type: EXPERIMENTAL
Intervention: External coaching
Number of subjects: 75

Group type: COMPARATOR
Intervention: No coaching (control)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: External coaching and No coaching (control)
Number of subjects: 75
Study: 32770831

Group type: EXPERIMENTAL
Intervention: CBDV (400 mg/day)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 32141781

Group type: EXPERIMENTAL
Intervention: GAT IOP measurement in sitting and left lateral decubitus positions for PXFG non-operated patients
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: GAT IOP measurement in sitting and left lateral decubitus positions for POAG non-operated patients
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: GAT IOP measurement in sitting and left lateral decubitus positions for PXFG operated patients
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: GAT IOP measurement in sitting and left lateral decubitus positions for POAG operated patients
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Comparison of GAT and Tonopen XL IOP measurements in LLDP
Number of subjects: 79
Study: 36121651

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 208
Study: 34070866

Group type: EXPERIMENTAL
Intervention: Warm-up with cloth facemask (EXP)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Warm-up without facemask (CON)
Number of subjects: 17
Study: 34325355

Group type: EXPERIMENTAL
Intervention: Metacarpal gloves
Number of subjects: 0
Study: 36012890

Group type: EXPERIMENTAL
Intervention: HPI monitoring
Number of subjects: 76

Group type: COMPARATOR
Intervention: Non-HPI
Number of subjects: 76
Study: 33420287

Group type: EXPERIMENTAL
Intervention: Reduced-dose posttransplant cyclophosphamide (20 mg/kg for MSD-PTCy cohort, 25 mg/kg for haplo-PTCy cohort) on days +3, +4 combined with cotransplantation of peripheral blood stem cells (PBSCs) and human umbilical cord-derived mesenchymal stem cells (UC-MSCs)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Reduced-dose posttransplant cyclophosphamide (20 mg/kg for MSD-PTCy cohort, 25 mg/kg for haplo-PTCy cohort) on days +3, +4 combined with cotransplantation of PBSCs and UC-MSCs
Number of subjects: 35
Study: 32006484

Group type: EXPERIMENTAL
Intervention: Primary augmented trabeculectomy
Number of subjects: 453

Group type: COMPARATOR
Intervention: Primary medical management
Number of subjects: 453